InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: codie post# 72921

Saturday, 02/07/2015 11:56:21 AM

Saturday, February 07, 2015 11:56:21 AM

Post# of 80868
the 2014 stock dilution is to blame for much of the low stock price right now....The company's market cap has grown in 2014, that is worth noticing.

No stock dilution or 1-2% stock dilution in 2015 is very likely, as most of the compensation based stock dilution and the near term endorsement based stock dilution is well behind Musclepharm.

Musclepharm might have planned to finance an acquisition with stocks, but that will have to wait for now.

Musclepharm will continue to focus on branding and sales, but with an ambition to become profitable.

Over the next few years, Brad should probably tone down his own compensation a little bit, because it's easier to make your employees work harder when the CEO is not making millions on their expense. As long as Musclepharm is a small public company, every single employee knows exactly how much the boss is making. Brad was a founder that built up the company, he deserved a large stock holding as incentive....but he needs to let the company make some money before he can write himself multi million dollar salaries...A company that doesn't make money quarter after quarter will eventually fail.


If the stock dilution madness doesn't stop, yeah, then the market cap will suffer and the stock will likely be $3-4. I have to say that I do see a lot of small companies in the US fail because of executive greed....I don't see much of that in Denmark to be honest, there the belief in the team is greater for sure...

Brad got a million shares though, and he should be entitled to a few million more if he uses the remaining 1 million stocks authorized for compensation....That should be incentive enough for him to get this stock back to $14 as soon as possible.

Brad lost half his net worth over 2 months, that's not cool for him!